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ABSTRACT  
Poor penetration of drug delivery nanocarriers within dense extracellular matrices constitutes one 
of the main liabilities of current nanomedicines. The conjugation of proteolytic enzymes on the 
nanoparticle surface constitutes an attractive alternative. However, the scarce resistance of these 
enzymes against the action of proteases or other aggressive agents present in the blood stream 
strongly limits their application. Herein, a novel nanodevice able to transport proteolytic 
enzymes coated with an engineered pH-responsive polymeric is presented. This degradable coat 
protects the housed enzymes against proteolytic attack at the same time that it triggers their 
release under mild acidic conditions, usually present in many tumoral tissues. These enzyme 
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nanocapsules have been attached on the surface of mesoporous silica nanoparticles, as 
nanocarrier model, showing a significatively higher penetration of the nanoparticles within 3D 
collagen matrices which housed Human Osteosarcoma cells (HOS). This strategy can improve 
the therapeutic efficacy of the current nanomedicines allowing a more homogeneous and deeper 
distribution of the therapeutic nanosystems in cancerous tissues.  
Keywords: Tumoral tissue penetration, collagenase nanocapsules, nanomedicine, mesoporous 
silica nanodevices and hybrid nanocarriers. 
 
INTRODUCTION 
 
Nanoparticles have become a powerful weapon in the fight against cancer due to their passive 
accumulation within solid tumors (EPR effect).1 This effect is caused by the distinctive tumoral 
blood vessels which present large pores and fenestrations of few hundred nanometers.2 Thus, 
when the nanoparticles reach the tumoral zone, they are able to escape from these highly 
permeable blood vessels producing the accumulation in the diseased tissue.3 Despite the huge 
importance of reaching the tumoral area, this is only the first step. The extravasated nanocarrier 
should be able to penetrate deeper into the solid tumor if a high therapeutic efficacy is pretended. 
Unfortunately, there are several physiological and physical barriers that should be overcome in 
order to achieve a homogeneous nanocarrier distribution in the entire malignant tissue.4 Tumoral 
tissues exhibit elevated interstitial fluid pressure (IFP) which hampers the convective transport 
making diffusion the de facto sole transport mechanism for nanocarriers. Moreover, solid tumors 
usually present extracellular matrices (ECM) denser than healthy tissues, with higher collagen 
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content which hinders even more the nanocarrier diffusion.5 The lack of an efficient nanoparticle 
distribution throughout all the diseased tissue reduces considerably the therapeutic efficiency of 
the nanomedicines and is one of their main liabilities.6 Different strategies have been postulated 
in order to overcome this limitation. Thus, the nanocarrier surface decoration with cell 
penetrating peptides (CPP) in combination with magnetic field guidance7 and even the use of 
self-propelled devices have been described to achieve a higher penetration in 3D tissues.8 A 
simpler approach consists in the local administration of proteolytic enzymes prior to the 
nanocarrier treatment, which has demonstrated a significant nanoparticle penetration 
enhancement within the tumoral tissue.9 Different proteolytic enzymes such as collagenase or 
bromelain have been directly anchored on the nanoparticle surface improving their diffusion in 
comparison with non-functionalized particles.10,11 However, enzymes are labile entities which 
can suffer a rapid degradation in living tissues by the action of proteases or other aggressive 
agents present in the blood stream. Even the attachment method can compromise the enzymatic 
activity as a consequence of conformational changes or active site blockage.12 Lu et al.13,14 have 
reported an interesting strategy which consists in the enzyme encapsulation into polymeric 
nanocapsules in order to improve their resistance and to preserve their activity during longer 
times. Our research group has described the attachment of enzyme nanocapsules onto the 
nanoparticle surface for the development of devices able to generate in situ cytotoxic 
compounds15 and also for the propulsion of nano- and micromotors.16 Herein, we describe the 
design and attachment of hybrid collagenase-polymeric nanocapsules on the surface of 
mesoporous silica nanoparticles in order to improve their penetration within 3D collagen 
matrices with tumoral cells embedded within the network, which mimic tumoral tissues. These 
polymeric nanocapsules protect the enzyme against proteolytic degradation and hydrolysis 
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during longer times improving enzyme performance while allowing higher matrix degradation 
and therefore, deeper penetration within the tissue (Scheme 1). 
 
Scheme 1. Synthesis and mechanism of pH-responsive polymeric nanocapsules for enhanced 
extracellular matrix degradation and tumoral tissue penetration. 
 
RESULTS AND DISCUSSION 
 
Synthesis and performance evaluation of the collagenase nanocapsules. 
 
Collagen is the most abundant component of the extracellular matrix. Thus, collagenase is one 
of the most suitable enzymes for ECM degradation. As mentioned above, a polymeric coating 
was built around the enzyme in order to preserve the activity against aggressive agents.  The 
enzyme substrate is a big molecule and therefore, the enzyme should be released from the 
capsule in order to be active for efficient collagen degradation. For this reason, a pH-responsive 
polymeric nanocapsule has been designed. This polymer coating undergoes slow degradation at 
physiological conditions (pH = 7) but exhibits a rapid hydrolysis at mild acidic conditions (pH = 
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5.5) which are naturally present in many tumoral tissues, as a consequence of their accelerated 
metabolism and the hypoxic environment.17 Thus, the enzyme will stay in an inactive stage until 
the pH becomes acidic, which will trigger the enzyme release with the subsequent collagen 
matrix degradation. 
Collagenase nanocapsules (Col-nc) were synthesized forming a polymeric coating around the 
native collagenase (Col) by radical polymerization employing a monomer mixture of acrylamide 
(AA) as structural monomer, hydrochloride salt of 2-aminoethylmethacrylate (Am) in order to 
provide amino groups on the capsule surface and ethylene glycol dimethacrylate (EG) as pH-
cleavable cross-linker. Different conditions were tested until the following optimal capsule 
formation parameters were found: monomer/protein molar ratio of 1:2025 and AA:Am:EG ratio 
(7:6:2). Thus, homogeneous protein nanocapsules were obtained with a diameter size around 50 
nm according to Dynamic Light Scattering (DLS) and Transmission Electron Microscopy 
(TEM). The spherical morphology and size of the capsules was confirmed by Atomic Force 
Microscopy (AFM) (Figure 1).  
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Figure 1. a) DLS of Col and Col-nc, b-c) TEM images of Col and Col-nc respectively, stained 
with phosphotungstic acid as contrast agent (scale bars correspond to 50 nm) and d-e) AFM of 
Col and Col-nc, respectively (scale bars correspond to 1 µm). 
The presence of free amino groups on the capsule surface was confirmed by fluorescamine 
assay. The enzymatic activity of the capsules was determined using a commercial kit (EnzCheck 
Gellatinase/Collagenase, Molecular Probes®) which is based in the measurement of the 
fluorescein released when fluorescently labeled gelatin was exposed to enzyme degradation. 
After the encapsulation process, the enzymatic activity suffers a drastic reduction of around 50% 
which indicates that the polymeric coating significatively hampers the collagen degradation by 
the encapsulated enzyme (Figure S1a).  
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This fact confirms that the enzyme should be released in order to achieve an efficient 
degradation of the collagen matrix, as it was mentioned above. For this reason, EG was 
employed as pH-cleavable cross-linker. This molecule exhibits rapid hydrolysis under mildly 
acidic conditions, compromising the stability of the whole capsule and hence releasing the 
housed enzyme. The pH-responsive nature of the capsule was evaluated by DLS suspending the 
capsules at different pH values, 7.0 and 5.5 respectively, during 2 hours. After this time, the 
capsule exposed to acidic pH was completely broken showing the same hydrodynamic diameter 
by DLS as the native enzyme, whereas the capsule exposed to neutral pH did not suffer any size 
modification. Interestingly, the enzymatic activity was almost fully recovered after the acidic 
treatment but it was kept at 50% when the sample was maintained at pH = 7. These results are 
consistent with a complete release of the trapped enzyme (Figure 2). 
 
Figure 2. pH-responsive behavior of Col-nc, a) DLS measurements of Col-nc exposed to pH = 
5.5 and 7, (purple and cyan lines, respectively) and b) Fluorescein released by a fluorescently 
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labeled collagen matrix treated with Col-nc previously exposed to pH = 5.5 and pH =7, (purple 
and cyan lines, respectively). 
 
Attachment of collagenase nanocapsules on the nanocarrier surface. 
 
Mesoporous silica nanoparticles (MSNs) have been chosen as nanomedicine model due to the 
excellent properties of this material such as high loading capacity and excellent biocompatibility, 
among others.18,19 Thus, MSNs were synthesized following the modified Stöber method reported 
elsewhere.20 According to DLS and TEM, the particles show a homogeneous size distribution 
centered around 140 nm which is convenient for their application as drug nanocarriers.21 In order 
to provide anchoring points for the protein nanocapsules, the surface of the particles was 
decorated with carboxylic groups by condensation of 4-(trietoxisililetilene)succidimide with the 
silanol groups on the surface, followed by hydrolysis in acidic medium. The presence of 
carboxylic groups was confirmed by the apparition of the characteristic C=O band at 1710 cm-1 
in the Fourier-Transform Infrared (FT-IR) spectrum and by Thermogravimetric Analysis (TGA). 
According with the DLS measurements, the particle size was maintained during this 
functionalization process (Figure S2).  
Enzyme nanocapsules were covalently grafted on the MSNs surface through the well-known 
carbodiimide chemistry. Thus, the carboxylic groups present on the MSN were transformed into 
activated esters through the reaction with N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC) and N-Hydroxysuccidimide (NHS). Then, the presence of free amino 
groups on the capsule surface produces their attachment on the particle surface by the formation 
of highly stable amide bonds producing the complete material (MSN-Col-nc). The same reaction 
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was carried out using native collagenase (MSN-Col) as control in order to compare the 
performance and stability of both systems. In both cases, FTIR spectra show a slight decrease in 
the carboxylic acid band at 1710 cm-1 and the appearance of two bands at 1650 and 1568 cm-1 
which correspond to amide bond formation and the protein. DLS measurements showed a size 
increase of around 50 nm, which corresponds to a discrete attachment of enzyme nanocapsules 
instead of to a complete covering of the entire surface (Figure S2). The conjugation of Col and 
Col-nc on the surface was confirmed by TEM using phosphotungstic acid as staining agent in 
order to increase the electron opacity of the organic material. In these images, the presence of the 
native enzymes attached on the silica surface is clearly visible as dark spots (Figure 3b) which 
are not present in naked MSN (Figure 3a). In the case of mesoporous silica particles decorated 
with collagen nanocapsules (MSN-Col-nc) these enzyme capsules are clearly visible attached on 
the particle surface, even keeping their round shape morphology (Figure 3c-d). TGA 
measurements and Sulfur analysis of the MSN-Col and MSN-Col-nc did not exhibit significative 
differences between them, showing in both cases around 6-8 % of grafted organic material. It is 
worth to note that MSN-Col-nc present high colloidal stability in aqueous media, being stable 
over time (Figure S3).  
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Figure 3. TEM images of a) MSN b) MSN-Col and c-d) MSN-Col-nc. Scale bars correspond to 
50 nm. Blue arrows point out the presence of Col and Col-nc. Due to the stochastic nature of the 
grafting procedure, the collagen nanocapsules are randomly distributed on MSN surface.   
 
Stability of MSN-Col-nc 
 
Obviously, MSN-Col initially presents higher enzymatic activity than MSN-Col-nc (Figure 
S1b) mainly by two reasons, first the absence of a polymeric coat as it has been mentioned above 
and secondly, the higher steric hindrance of the capsules which causes a lower enzyme 
nanocapsules grafting in comparison with the native protein attachment. However, despite this 
initial advantage, the enzymatic activity of MSN-Col decreases in a short period of time when 
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the samples are suspended in a PBS buffer solution at pH = 7 and 37 ºC whereas the activity 
increases to double its initial value in the case of MSN-Col-nc. This behavior proves that the 
polymeric coat which wraps the enzyme suffers hydrolysis and the housed enzymes are slowly 
released or exposed fully recovering their capacity to digest collagen after longer periods of time 
(Figure 4a). It is important to remark that a similar amount of free enzyme almost completely 
loses its activity after a short incubation time of two hours in these conditions.  One important 
role which should be played by the polymeric coat consists in the protection of the encapsulated 
enzyme against proteolytic attack, because the lack of stability against proteases is the main 
limitation on the use of proteins in clinical applications.22 In order to compare the stability 
against proteases, samples MSN-Col and MSN-Col-nc were suspended at 37 °C in a solution of 
PBS (pH = 7) which contains 1 mg·mL-1 of Protease from Streptomyces griseus. The results 
indicate that material with the uncoated enzyme lost more than 60% of its enzymatic activity 
after 3 hours while the sample with enzyme nanocapsules kept intact their activity (Figure 4b). 
All these experiments evidence the protective role of the polymeric nanocapsules. 
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Figure 4. Stability test of MSN-Col and MSN-Col-nc against a) hydrolysis and b) Proteolytic 
attack c) ECM degradation by MSN-Col-nc. 
 
EMC degradation capacity of MSN-Col-nc 
 
The capacity of the protein capsules attached on the particle surface to degrade the 
extracellular matrix was initially tested using a 3D collagen matrix formed by MaxGelTMECM. 
This 3D matrix is composed by several human extracellular matrix components such as collagen, 
laminin, fibronectin, tenascin, elastin, and a number of proteoglycans and glycosaminoglycans 
which mimic the matrices present in human living tissues.11 The proteins which form the 3D 
matrix were previously stained with fluorescein isothiocyanate (FITC) in order to monitorize the 
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matrix degradation through the measurement of the fluorescein released after addition of the 
nanoparticles. Naked MSN, which shows negligible enzymatic activity (Figure S4) was used as 
control. A suspension of 1 mg·mL-1 of MSN-Col-nc and MSN respectively, was carefully added 
on top of the fluorescent 3D gels and both samples were incubated at 37 °C during 24 hours. 
After this time, a strong fluorescence was observed in the case of MSN-Col-nc whereas a scarce 
fluorescence was observed in the case of naked MSN (Figure 4c). The particles decorated with 
collagenase nanocapsules present a five-fold increase in the ECM degradation in comparison 
with the non-functionalized ones.  
 
Penetration capacity of MSN-Col-nc in 3D-Human Osteaosarcoma-seeded collagen gels. 
 
A 3D-tumoral tissue model was prepared in order to study the MSN-Col-nc performance in a 
more realistic model which takes into account the influence that could exert the presence of 
tumoral cells embedded within the matrix.  To this end, a 3D-collagen gel which contains 
Human Osteosarcoma cells (HOS) was synthesized following a slightly modified procedure 
reported elsewhere (Figure S5).7 This matrix shows similar consistency to real human tissue and 
the presence of embedded tumoral cells provides a realistic environment for testing the 
penetration capacity of nanocarriers clothed with these enzyme capsules. In order to visualize the 
penetration of the nanoparticles within the collagen gel, MSNs were synthesized carrying 
fluorescein molecules covalently grafted within their structure following a procedure reported 
elsewhere.27 The stability of the fluorescein molecules covalently grafted within the silica matrix 
was evaluated suspending a certain solution of fluorescent MSN in PBS buffer at pH =7 and 37 
ºC and measuring by fluorescence spectroscopy the fluorescein lixiviated in the supernatant and 
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the fluorescence remained in the particles over time (Figure S6). The absence of lixiviated 
fluorescein confirms the stability of the FITC covalent grafting protocol. After this, collagenase 
and collagenase nanocapsules were grafted on the fluorescent MSN surface through the same 
conjugation method employed for non-fluorescent MSN. A suspension of fluorescent MSN and 
MSN-Col-nc, respectively (25 µg·mL-1) was carefully placed on top of the 3D-gels; the 
penetration capacity of each carrier was evaluated by confocal fluorescence microscopy after 24 
hours of incubation. The results indicated that the naked particles were not able to penetrate 
within the gel and remained fixed on the top layer, whereas MSN-Col-nc exhibited an improved 
penetration within the 3D-matrix (Figure 5a-b). It is worthy to point out that if the concentration 
of MSN-Col-nc was doubled, a drastic decrease of the matrix thickness was observed up to reach 
only one third of the original size (Figure 5c). This fact indicates that the released collagenase 
diffuses throughout the matrix causing a higher collagen digestion as a consequence of their 
higher concentration in this case.  
 
 
Figure 5. Penetration in 3D-HOS-seeded collagen gels of a) MSN and b) MSN-Col-nc using a 
particle concentration of 25 µg·mL-1, respectively (White arrows indicate the presence of clusters 
of MSN-Col-nc). c) Penetration of MSN-Col-nc using a concentration of 50 µg·mL-1. Red 
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arrows correspond to a gel thickness of 740 µm. Yellow arrow corresponds to a gel thickness of 
280 µm. 
 
Cytotoxicity studies of MSN-Col-nc. 
It has been reported that collagenase, both alone23 or conjugated on the surface of different 
nanoparticles24,25 causes very low toxicity in human cells. Additionally, MSN is also a 
biocompatible material.26 However, our system is composed by a novel type of collagenase 
nanocapsules grafted on the MSN surface and its cytotoxicity should be evaluated. Thus, HOS 
cells were incubated in the presence of a fixed concentration of naked MSN and MSN-Col-nc 
(25 µg·mL-1, which is the optimal concentration for tissue penetration) during 24 hours and their 
cell viability was evaluated measuring the Lactate deshydrogenase (LDH) released in the media. 
As shown in Figure 6a, the exposition to naked particles and particles decorated with the 
enzyme nanocapsules did not cause higher LDH release in comparison with the negative control 
which corresponds to untreated cells. In order to simulate a highly cytotoxic material, as positive 
control, the cells were exposed to a solution of Triton X (2%) which caused their complete 
destruction and a subsequent LDH increment of more than four times. The absence of 
cytotoxicity caused by the exposition to these materials was confirmed using the standardized 
cell viability test by MTS reduction that exhibit similar values in all systems (Figure 6b). These 
results indicate that neither of the materials provokes a substantial cell death.  
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Figure 6. a) LDH assay of MSN and MSN-Col-nc where Control (-) are cells without treated 
with particles and Control (+) are cells lysed with Triton X in order to simulate full cytotoxicity.  
b) Cell viability assay by MTS test of MSN and MSN-Col-nc c-d) Merged microscopy images of 
HOS cells incubated with MSN and MSN-Col-nc labeled with fluorescein. Blue stain 
corresponds to cell nucleus, green stain corresponds to nanoparticles and red stain corresponds to 
lysosomes (Scale bar correspond to 100 µm). Each channel can be separately observed in Figure 
S7. e-f) Fluorescence intensity of each fluorophore emission wavelength along the white arrow 
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in c-d images (red pattern correspond to lysosomes, green pattern correspond to MSN and MSN-
Col-nc and blue pattern correspond to cell nuclei). 
In order to visualize if the nanoparticles were internalized within the tumoral cells, the 
lysosomes were stained using Cell NavigatorTM Lysosome Staining Kit showing that the 
nanoparticles were mainly located within these cell organelles (Figure 6c-d). Additionally these 
results were confirmed measuring independently the fluorescence intensity of each fluorophore 
obtaining a clear pattern which shows that nanoparticles are mainly located in the same place 
than lysosomes and outside the cell nuclei (Figure 6e-f).  
 
CONCLUSIONS 
In conclusion, a novel strategy to transport collagenase attached on the surface of a nanocarrier 
and to release it in a controlled manner has been presented. This approach is based on the 
synthesis of hybrid enzyme-polymer nanocapsules which have been engineered to exhibit slow 
enzyme release at physiological conditions or faster if the pH drops to mild-acidic values, which 
is characteristic of many tumoral tissues. Moreover, these capsules protect the enzymes against 
proteolytic attack by proteases, which is one of the main limitations of employing enzymes in 
living tissues, maintaining their activity during long times. Finally, the attachment of these 
enzyme capsules on the surface of a model nanocarrier has afforded a significant improvement of 
their penetration within a tumoral tissue model as a consequence of the abundant extracellular 
matrix degradation caused by the in situ released collagenase. These properties would be of 
paramount importance for clinical applications paving the way for the development of more 
efficient nanomedicines able to achieve deeper penetration and more homogeneous distribution 
within the tumoral tissues. 
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EXPERIMENTAL SECTION 
 
Synthesis of Collagenase Capsule (Col-nc): 3.1·10-5 mmol of collagenase was dissolved in 1 
mL of NaHCO3 buffer (0.01M pH = 8.5), previously deoxygenated three times for freeze-vacum-
N2 cycles, at room temperature. 0.035 mmol of acrylamide (AA), 0.026 mmol of 2-
Aminometacrylate hydrochloride (Am) and 0.01 mmol of Ethylene glicol dimetacrylate (EG) 
were dissolved in 1 mL of deoxygenated NaHCO3 (0.01M pH = 8.5) buffer and were added to 
the solution of collagenase. This mixture was stirred at 300 rpm for 10 min under nitrogen 
atmosphere at room temperature. Then, 0.013 mmol of ammonium persulfate and 0.002 mmol of 
N,N,N’,N’-Tetramethyl ethylenediamine (TMDA) dissolved in 1 mL of the deoxygenated 
NaHCO3 buffer (0.01M pH = 8.5) were added. The solution was stirred at 300 rpm for 90 min at 
room temperature under inert atmosphere. After this time, the  encapsulated enzyme was purified 
by centrifugal separation with 10 kDa cut-of filters (AMICON Ultra-2mL 10KDa) and washed 
three times with NaHCO3 buffer (0.01M pH = 8.5). The capsules of collagenase were preserved 
at 4 °C. 
Synthesis of Mesoporus Silica Nanoparticles: 2.74 mmol of Hexadecyltrimethylammonium 
bromide (CTAB), 480 mL of water and 7 mmol of NaOH were stirred at 600 rpm at 80 °C. 
Then, 22.4 mmol of tetraethylortosilicate (TEOS) was added slowly during 20 minutes and upon 
addition, the mixture was stirred during two hours at 80 ºC. Then, the particles were collected by 
centrifugation and washed three times with water and ethanol.  The surfactant was removed 
placing the particles in 500 mL of a solution of 95% ethanol, 5% water and 10 g NH4NO3 mL
-1 
at 80 °C during two hours under intense stirring.  The same cycle was repeated two times more 
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in order to remove all the surfactant. The nanoparticles were dried under vacuum and preserved 
at room temperature. 
 For penetration studies within 3D gels, fluorescent nanoparticles were synthesized following 
an analogous protocol described elsewhere.27 Briefly, FITC (1mg) and APTES (2,2 µL) were 
dissolved in the minimum volume of EtOH and the mixture was stirred at room temperature for 2 
hours under N2 atmosphere. Then, this solution was mixed with 22. 4 mmol of TEOS and the 
particles were synthesized following the same method mentioned above. 
Synthesis of acid-funcionalizated Silica Nanoparticles (MSN): 500 mg of the particles 
obtained above and 1.34 mmol of anhydrous 4-(trietoxisililetilene)succidimide were suspended 
in 50 mL of dry toluene under inert atmosphere at 110 °C under intense stirring overnight. Then, 
the nanoparticles were collected by centrifugation and washed with toluene, tetrahydrofuran and 
finally with water, in order to hydrolyze the succinic anhydride providing the carboxylic acid 
groups. The particles were dried under vacuum and preserved at room temperature. 
Attachment of Native Collagenase on Silica Nanoparticles (MSN-Col): A suspension of 50 
mg of MSN in 2 mL PBS (pH = 7) was treated with 0.03 mmol of N-(3-Dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC) and 0.04 mmol of N-Hydroxysuccidimide (NHS). 
The pH was fixed to pH = 8.5 adding 0.06 mmol of sodium carbonate. The sample was placed in 
an orbital stirrer at 400rpm during 10 min and after this time, 3.1·10-4 mmol of collagenase were 
added and the mixture was stirred during 4h. The sample was collected by centrifugation and 
washed three times with PBS. The sample was preserved at 4 ºC. 
Attachment of Collagenase nanocapsules on Silica Nanoparticles (MSN-Col-nc): A 
suspension of 50 mg of MSN in 2 mL PBS (pH = 7) was treated with 0.03 mmol of N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and 0.04 mmol of N-
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Hydroxysuccidimide (NHS). The pH was fixed to pH = 8.5 adding 0.06 mmol of sodium 
carbonate. The sample was placed in an orbital stirrer at 400rpm during 10 min and after this 
time, 10 mg of collagenase nanocapsules were added and the mixture was stirred during 4 h. The 
sample was collected by centrifugation and washed three times with PBS. The sample was 
preserved at 4 ºC. 
Enzymatic activity measurements: The enzymatic activity of all samples was evaluated 
using and following the protocol EnChek®Gelatinase/Collagenase Assay Kit. For this 
experiment, 80 µl of collagenase buffer 1x, 20 µL of Collagen-FITC and 100 µL of each sample 
were used. 
Study pH Responsive of MSN-Col-nc: 
Size measurements by DLS: 100 µL of the encapsulated collagenase (Col-nc) was dissolved in 
2 mL of HPLC water. The initial hydrodynamic diameter of the capsules was characterized by 
DLS and it was compared with the size of the native collagenase (Col). 1 mL of this solution was 
placed into a pur-A-lyzer (6 kDa) which was submerged in a flask with 200 mL of PBS Buffer 
pH = 7.0 at 37 °C with magnetic stirring for 2 h. Another batch of 1 mL was similarly treated but 
in this case using a solution of 200 mL of PBS Buffer pH = 5.5. After this time, the changes in 
the hydrodynamic diameter of both batches were evaluated by DLS. 
Enzymatic Activity: 150 µL of the encapsulated collagenase (Col-nc) was suspended in 1mL of 
PBS buffer 0.01 M pH = 7. One batch of 400 µL of this solution was placed into a pur-A-lyzer (6 
kDa) submerged in 200 mL of the same buffer at 37 °C with magnetic stirring during 4h. 
Another batch was placed into a pur-A-lyzer  (6 kDa) submerged in 200 mL of PBS Buffer pH = 
5.5 at 37 °C for 3 h and 1 h more in PBS buffer 0.01 M pH = 7 at 37 ºC in order to equilibrate the 
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pH before performing the enzymatic activity measurements. Then, both batches were diluted 
1:100 in PBS and then the enzymatic activity of the capsules solution was evaluated. 
Study of the Enzymatic Activity of MSN-Col and MSN-Col-nc:  
Stability during the time: 2 mg of silica nanoparticles functionalized with native and 
encapsulated collagenase (Col and Col-nc, respectively) were suspended in PBS 0.01M at pH = 7 
at 37 ºC and their enzymatic activity was studied at different times. 
Study Enzymatic activity against proteases: Two batches of 1 mg of the MSN-Col-nc and 
MSN-Col were suspended respectively in a solution of 1mg·mL-1 Protease from Streptomyces 
griseus in PBS Buffer 0.01 M (pH = 7).  Both samples were incubated at 37 °C during the 
corresponding time and after this time, they were washed ten times with the same buffer in order 
to remove the proteases. Then, the enzymatic activity of the nanoparticles was measured using 
the protocol mentioned above.  
ECM degradation by MSN-Col-nc: MaxGelTMECM was diluted 1:2 in a cold solution of 
0.0026 mmol/mL of Fluorescein isomer I (FITC) in PBS 0.01 M pH = 7. Then the solution was 
pipetted into 96 well plates and incubated for 5h at 37°C in order to promote the gelation. Once 
the gel was formed, the supernatant was removed and the gel was gently washed until the 
observation of neglictable fluorescence in the supernatant. 200 µL of a suspension of 1 mg·mL-1 
of MSN and MSN-Col-nc in PBS 0.01 M pH = 7 respectively, was pipetted on the ECM gel and 
incubated at 37 °C during 24 h. Then, the fluorescence of supernatant was analyzed. 
Preparation of 3D-Human Osteaosarcoma-seeded collagen gels: 2 mL of rat tail 
CollagenType I and 0.6 mL of complete medium (Dulbecco’s modified eagle’s medium 
complemented with 10% of FBS) were mixed in cold and 100µL of sodium hydroxide were 
added to obtain a mixture of neutral pH. To this solution,  0.5 mL of FBS, 0.5mL of complete 
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medium and 0.5 mL of a solution of cells of concentration HOS 1:106 cell/mL was added, 
keeping the temperature at 0 ºC. The mixture was pipetted into 12 well plates (0.5mL/well) and 
incubated at 37 °C at 5% CO2 atmospheric concentration for 1 h to promote gel formation. Then 
500 µL of complete medium was added in each well and the gel was incubated at 37 °C at 5% 
CO2 atmospheric concentration overnight. After this time, a needle was run around the edge of 
each solid gel to detach it from the plastic and 0.5 mL of complete medium was added. Gels 
were used in experiments four days after detachment to allow full gel contraction. 
Study of penetration of MSN-Col-nc in HOS-collagen gels: To study the penetration of 
nanocarriers in 3D gels with cells HOS embedded, the medium which cover the gels was 
removed and the corresponding amount of suspended MSN and MSN-Col-nc  (1 mg ·mL-1) was 
added on top of each gel. These samples were incubated at 37 °C at 5% CO2 atmospheric 
concentration during 24h. Then, the supernatant was removed and the gel was fixed at 4 ºC 
during 1 h with 0.5 ml of a solution of glutaraldehyde at 2.5 % of concentration. Then, confocal 
fluorescence microscope (using 10x magnifications) was used to determine the penetration by z-
stack images of each gel, composed of sequential images taken 2 µm apart. Each compressed z-
stack was analyzed and used for statistical analysis and graphical representation. 
Cell viability studies: 
The cytotoxicity of nanocarriers was evaluated using the standard LDH activity test and the 
MTS reduction assay protocol. For this study 20000 cells HOS·cm-2 were seeded into each well 
of a 24 well plate, 0.5mL of complete media was added to each well and the cells were cultured 
at 37 °C at 5% CO2 atmospheric concentration for 24h. Then, the cells were incubated with the 
corresponding sample MSN and MSN-Col-nc, at 25 µg·mL-1 or without particles in the case of 
controls (+) and (-), during 24 h at 37 °C at 5% CO2 atmospheric concentration. In the case of 
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control (+) a suspension of Triton X (2%) was added and the cells were incubated during 2h.  
After this time, the supernatant was collected for measuring the extracellular LDH activity. The 
cells were washed with 0.5 mL of PBS twice and 0.3 mL of a solution of 2 mL of MTS in 10 mL 
of complete medium was added. The cell culture was incubated at 37 °C at 5% CO2 atmospheric 
concentration for 4h and then the supernatant was collected for the MTS assay. 
Lactate dehydrogenase (LDH) assay: Extracellular LDH activity was measured using 33 µL of 
supernatant and 1000 µL of the kit for Quantitative determination of LDH (Spinreact®). The 
LDH activity was measured by spectrophotometer at 340 nm in the culture medium following 
the manufacturer protocol. 
MTS assay: The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) reduction assay was performed using a commercial assay and 
following the manufacturer protocol (CellTiter® Aqueous One Solution Cell Proliferation 
Assay). The absorption of supernatant was measured at 490 nm using a microplate reader. 
Fluorescence microscopy images of HOS exposed to MSN and MSN-Col-nc.  
For this study, HOS cells were exposed during 24 h to the same nanoparticle concentration (25 
µg·mL-1) of MSN and MSN-Col-nc covalently labeled with fluorescein as in the previously 
mentioned assays. 
 In order to visualize lysosomes, a staining kit (Cell NavigatorTM Lysosome Staining Kit) was 
employed. Briefly, 20 µl of LisoBriteTM Red, 4.98 ml of Live Cell Staining Buffer and 5 ml of 
complete media were mixed. 600 µl of these dilutions were added into each well of a 24 well 
plate which contains the cells and they were incubated for 30 min at 37 ºC. Then, the supernatant 
was removed and the cells were washed with 0.5 mL of PBS twice. To visualize the cells nuclei, 
600 µl of 1 µg/ml DAPI in methanol was added into each well and the cells were incubated for 
 24 
1min at 37 ºC. Finally, the supernatant was removed and the cells were washed with 0.5 mL of 
PBS twice. 
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SYNOPSIS TOC. Enhanced 3D-tumoral tissue nanocarrier penetration by proteolytic enzymes 
housed within a degradable nanocapsules, which protect them against proteolytic attack at the 
same time that allows their release under mild acidic tumoral conditions.  
 
 
